liver fibrosismetabolic dysfunction-associated steatohepatitiscarbon tetrachloride
…SG15-CREB1 signalling may be a potential therapeutic target for liver fibrosis.…
26articles mentioning diseases
28disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Metabolic Dysfunction-Associated Steatohepatitis
This disease is selected. Its supporting articles are shown below.
Articles mentioning Metabolic Dysfunction-Associated Steatohepatitis
26 articles · page 2 of 3hepatic fibrosishepatocellular carcinomametabolic dysfunction-associated steatohepatitischolangiopathies
… carcinoma, metabolic dysfunction-associated steatohepatitis or hepatic fibrosis. Nevertheless, significant barriers prevent the widespread adop…
Metabolic dysfunction-associated steatohepatitisMASHfibroblast growth factor-21 analoguesdiacylglycerol O-acyltransferase 2 inhibitorsthyroid hormone receptor-beta (THR-β) agonistsperoxisome proliferator-activated receptor agonistsglucagon-like peptide-1 (GLP-1) receptor agonistsTHR-β agonistsacetyl-CoA carboxylase (ACC) inhibitorsmultitargeted combination therapies
…Metabolic dysfunction-associated steatohepatitis (MASH) is a multifactorial metabolic liver disease that occurs …
liver fibrosisviral hepatitismetabolic dysfunction-associated steatotic liver disease (MASLD)chronic hepatitis B (CHB)metabolic dysfunction-associated steatohepatitisARMMASLDThrombospondin 2 (TSP-2)
…3 4 Given the critical importance of non-invasive assessment of liver fibrosis for the clinical management of CHB,5 we evaluated the predictiv…
PBCprimary biliary cholangitisprimary sclerosing cholangitisPSCmetabolic dysfunction-associated steatohepatitisMASHautoimmune hepatitisNumeric Rating ScaleWorst Itch Numeric Rating Scale
…aracterised the severity, persistence and impact of pruritus in PBC, PSC, chronic hepatitis B or C virus infection (HBV/HCV), drug-…
hepatocellular carcinomatype 2 diabetesMetabolic dysfunction-associated steatotic liver diseaseMASHmetabolic dysfunction-associated steatohepatitiscirrhosisliver failureMASLDsemaglutide1 2resmetirom+1 more
…patitis (MASH), which is linked to cirrhosis, liver failure and hepatocellular carcinoma. The recent approval of resmetirom and semaglutide1 2 for activ…
hepatocellular carcinomaliver ischaemia-reperfusion injuryinflammatory bowel diseasemetabolic dysfunction-associated steatohepatitismetabolic dysfunction-associated steatotic liver diseasecolorectal and pancreatic cancersgastrointestinal malignanciesdrug-induced liver injury
…-induced liver injury and gastrointestinal malignancies such as hepatocellular carcinoma, colorectal and pancreatic cancers. CD47 contributes to disease…
Liver cancerliver cirrhosishepatocellular carcinomaMetabolic Dysfunction-Associated SteatohepatitisPrimary Biliary CholangitisHepatitis CHepatitis BLiver DiseaseHCCJames Paget University Hospital+2 more
…Background Liver cancer is the fastest-rising cause of cancer-related deaths in the UK,…
Metabolic dysfunction-associated steatotic liver disease (MASLD)Metabolic Dysfunction-Associated SteatohepatitisT2DMMASLD-related advanced fibrosisSemaglutidetertiary hepatology centre
…Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a global epidemic and leading indication for liver t…
metabolic syndromecirrhosismetabolic dysfunction-associated steatohepatitisMetabolic dysfunction-associated steatotic liver diseaseHCCMASLDBritish Liver Trustdrug therapy
…ent, a Fibroscan, and completion liver screen. Interrogation of metabolic syndrome risk factors and alcohol screening takes place, with appropriat…
Obesitymetabolic dysfunction-associated steatotic liver diseasemetabolic dysfunction-associated steatohepatitisobstructive sleep apneaMASLDSt. Vincent’s Hospital Groupbariatric surgery
…Background Obesity is a growing global epidemic affecting over one billion people.…